Cargando…
A Bidirectional Permeability Assay for beyond Rule of 5 Compounds
Bidirectional permeability measurement with cellular models grown on Transwell inserts is widely used in pharmaceutical research since it not only provides information about the passive permeability of a drug, but also about transport proteins involved in the active transport of drug substances acro...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400635/ https://www.ncbi.nlm.nih.gov/pubmed/34452112 http://dx.doi.org/10.3390/pharmaceutics13081146 |
_version_ | 1783745361498603520 |
---|---|
author | Cui, Yunhai Desevaux, Cyril Truebenbach, Ines Sieger, Peter Klinder, Klaus Long, Alan Sauer, Achim |
author_facet | Cui, Yunhai Desevaux, Cyril Truebenbach, Ines Sieger, Peter Klinder, Klaus Long, Alan Sauer, Achim |
author_sort | Cui, Yunhai |
collection | PubMed |
description | Bidirectional permeability measurement with cellular models grown on Transwell inserts is widely used in pharmaceutical research since it not only provides information about the passive permeability of a drug, but also about transport proteins involved in the active transport of drug substances across physiological barriers. With the increasing number of investigative drugs coming from chemical space beyond Lipinski’s Rule of 5, it becomes more and more challenging to provide meaningful data with the standard permeability assay. This is exemplified here by the difficulties we encountered with the cyclic depsipeptides emodepside and its close analogs with molecular weight beyond 1000 daltons and cLogP beyond 5. The aim of this study is to identify potential reasons for these challenges and modify the permeability assays accordingly. With the modified assay, intrinsic permeability and in vitro efflux of depsipeptides could be measured reliably. The improved correlation to in vivo bioavailability and tissue distribution data indicated the usefulness of the modified permeability assay for the in vitro screening of compounds beyond the Rule of 5. |
format | Online Article Text |
id | pubmed-8400635 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84006352021-08-29 A Bidirectional Permeability Assay for beyond Rule of 5 Compounds Cui, Yunhai Desevaux, Cyril Truebenbach, Ines Sieger, Peter Klinder, Klaus Long, Alan Sauer, Achim Pharmaceutics Article Bidirectional permeability measurement with cellular models grown on Transwell inserts is widely used in pharmaceutical research since it not only provides information about the passive permeability of a drug, but also about transport proteins involved in the active transport of drug substances across physiological barriers. With the increasing number of investigative drugs coming from chemical space beyond Lipinski’s Rule of 5, it becomes more and more challenging to provide meaningful data with the standard permeability assay. This is exemplified here by the difficulties we encountered with the cyclic depsipeptides emodepside and its close analogs with molecular weight beyond 1000 daltons and cLogP beyond 5. The aim of this study is to identify potential reasons for these challenges and modify the permeability assays accordingly. With the modified assay, intrinsic permeability and in vitro efflux of depsipeptides could be measured reliably. The improved correlation to in vivo bioavailability and tissue distribution data indicated the usefulness of the modified permeability assay for the in vitro screening of compounds beyond the Rule of 5. MDPI 2021-07-27 /pmc/articles/PMC8400635/ /pubmed/34452112 http://dx.doi.org/10.3390/pharmaceutics13081146 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Cui, Yunhai Desevaux, Cyril Truebenbach, Ines Sieger, Peter Klinder, Klaus Long, Alan Sauer, Achim A Bidirectional Permeability Assay for beyond Rule of 5 Compounds |
title | A Bidirectional Permeability Assay for beyond Rule of 5 Compounds |
title_full | A Bidirectional Permeability Assay for beyond Rule of 5 Compounds |
title_fullStr | A Bidirectional Permeability Assay for beyond Rule of 5 Compounds |
title_full_unstemmed | A Bidirectional Permeability Assay for beyond Rule of 5 Compounds |
title_short | A Bidirectional Permeability Assay for beyond Rule of 5 Compounds |
title_sort | bidirectional permeability assay for beyond rule of 5 compounds |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8400635/ https://www.ncbi.nlm.nih.gov/pubmed/34452112 http://dx.doi.org/10.3390/pharmaceutics13081146 |
work_keys_str_mv | AT cuiyunhai abidirectionalpermeabilityassayforbeyondruleof5compounds AT desevauxcyril abidirectionalpermeabilityassayforbeyondruleof5compounds AT truebenbachines abidirectionalpermeabilityassayforbeyondruleof5compounds AT siegerpeter abidirectionalpermeabilityassayforbeyondruleof5compounds AT klinderklaus abidirectionalpermeabilityassayforbeyondruleof5compounds AT longalan abidirectionalpermeabilityassayforbeyondruleof5compounds AT sauerachim abidirectionalpermeabilityassayforbeyondruleof5compounds AT cuiyunhai bidirectionalpermeabilityassayforbeyondruleof5compounds AT desevauxcyril bidirectionalpermeabilityassayforbeyondruleof5compounds AT truebenbachines bidirectionalpermeabilityassayforbeyondruleof5compounds AT siegerpeter bidirectionalpermeabilityassayforbeyondruleof5compounds AT klinderklaus bidirectionalpermeabilityassayforbeyondruleof5compounds AT longalan bidirectionalpermeabilityassayforbeyondruleof5compounds AT sauerachim bidirectionalpermeabilityassayforbeyondruleof5compounds |